BAM
COLL icon

Bellevue Asset Management’s Collegium Pharmaceutical COLL Stock Holding History

Bellevue Asset Management’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-71
Closed -$1K – 645
2020
Q3 		$1K Hold
71
– – ﹤0.01% 593
2020
Q2 		$1K Hold
71
– – ﹤0.01% 586
2020
Q1 		$1K Buy
71
+37
+109% +$764 ﹤0.01% 556
2019
Q4 		$1K Buy
+34
New +$567 ﹤0.01% 485

Other funds holding COLL

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

Bellevue Asset Management's COLL Position: Q4 2020 in Review

Bellevue Asset Management sold out of Collegium Pharmaceutical (COLL) in Q4 2020, closing a stake of 71 shares — an estimated $1K sold.

Bellevue Asset Management first reported a position in COLL in Q4 2019 and held it in 4 quarters. The position peaked at $1K in Q3 2020. 138 funds tracked by Wall St. Rank hold COLL as of Q4 2020.

  • Bellevue Asset Management reported no remaining Collegium Pharmaceutical position as of Q4 2020 after selling out during the quarter.
  • Bellevue Asset Management sold 71 Collegium Pharmaceutical shares in Q4 2020, an estimated $1K.
  • Bellevue Asset Management first reported a position in Collegium Pharmaceutical in Q4 2019 and held it in 4 quarters.
  • Bellevue Asset Management's Collegium Pharmaceutical position peaked at $1K in Q3 2020.
  • 138 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q4 2020.

Based on Bellevue Asset Management's 13F filing for Q4 2020, filed 11 Feb 2021.